A detailed history of Citigroup Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Citigroup Inc holds 7,143 shares of BHC stock, worth $55,143. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,143
Previous 12,289 41.87%
Holding current value
$55,143
Previous $85,000 31.76%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$5.22 - $8.26 $26,862 - $42,505
-5,146 Reduced 41.87%
7,143 $58,000
Q2 2024

Aug 12, 2024

SELL
$6.1 - $10.41 $17,214 - $29,377
-2,822 Reduced 18.68%
12,289 $85,000
Q1 2024

May 10, 2024

BUY
$7.77 - $10.61 $25,866 - $35,320
3,329 Added 28.25%
15,111 $160,000
Q4 2023

Feb 09, 2024

SELL
$6.53 - $8.23 $59,018 - $74,382
-9,038 Reduced 43.41%
11,782 $94,000
Q3 2023

Nov 09, 2023

BUY
$7.69 - $9.71 $67,702 - $85,486
8,804 Added 73.27%
20,820 $171,000
Q2 2023

Aug 10, 2023

SELL
$5.72 - $8.8 $3.95 Million - $6.08 Million
-690,468 Reduced 98.29%
12,016 $96,000
Q1 2023

May 11, 2023

BUY
$6.28 - $9.85 $4.03 Million - $6.32 Million
641,917 Added 1059.85%
702,484 $5.69 Million
Q4 2022

Feb 09, 2023

SELL
$6.09 - $7.93 $2.86 Million - $3.72 Million
-469,073 Reduced 88.56%
60,567 $380,000
Q3 2022

Nov 10, 2022

BUY
$4.58 - $9.21 $1.36 Million - $2.73 Million
296,856 Added 127.52%
529,640 $3.68 Million
Q2 2022

Aug 10, 2022

BUY
$7.06 - $23.63 $72,160 - $241,522
10,221 Added 4.59%
232,784 $1.94 Million
Q1 2022

May 12, 2022

BUY
$21.6 - $27.79 $3.89 Million - $5.01 Million
180,214 Added 425.54%
222,563 $5.09 Million
Q4 2021

Feb 10, 2022

BUY
$23.0 - $29.01 $410,412 - $517,654
17,844 Added 72.82%
42,349 $1.17 Million
Q3 2021

Nov 10, 2021

BUY
$25.04 - $30.06 $613,605 - $736,620
24,505 New
24,505 $683,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.79B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.